Senate panel opens inquiry into EpiPen pricing

WASHINGTON - A Senate panel has opened a preliminary investigation into why the price of lifesaving EpiPens has skyrocketed.The top Republican and Democrat on the Senate Homeland's investigations subcommittee said in a statement Wednesday that they began an inquiry into Mylan Pharmaceuticals' pricing and competition practices. Mylan has been sharply criticized for its steep price increases for the emergency allergy treatment EpiPen.The price has grown to $608 for a two-pack, up more than 500 per